The Wall Street Journal hinted today why drug companies like Bristol-Myers and Johnson & Johnson are in the infectious disease business. (Note Vertex began the clinical development of Telaprevir in 2004 and is collaborating with Johnson & Johnson and Mitsubishi Tanabe Pharma) According to Jonathan D. Rockoff from the WSJ, patients in the U.S. can't afford the high cost of prescriptions and the European governments with their own financial obstacles are working to control price increases. The drug business is taking a hit because of the economy. The business of antiviral agents are giving these drug companies a shot at some real cash flow. The buzz is J&J may expand in infectious disease, as for Bristol-Myers they came out with their own sad earnings today. (See more on Bristol-Myers at Wall Street Journal )
. .
Bristol’s is developing BMS-790052 NS5A Inhibitor plus BMS-650032 Protease Inhibitor for treating HCV. The company is recruiting patients in their phase II trial "Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care" (see trial status ) and locations below.
.
Additional information on the blog: (BMS-790052) With Peginterferon/Ribavirin Trials
.
Note:
New data on multiple Bristol-Myers Squibb Company compounds will be presented at the 61st annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from beginning this Friday : October 29 to November 2.
.
Note:
New data on multiple Bristol-Myers Squibb Company compounds will be presented at the 61st annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from beginning this Friday : October 29 to November 2.
Read complete article here...
Contacts
Contact: For participation information at a USA site use a phone number below. For site information outside the USA please email:
mailto:Clinical.Trials%40bms.com?subject=NCT01012895,
Contact: First line of email MUST contain NCT# & Site#. Only trial sites that are recruiting have contact information at this time.
Locations
United States, California
Advanced Clinical Res Inst
Recruiting
Anaheim, California, United States, 92801
Contact: Michael Demicco, Site 004 714-774-7777
San Jose Gastroenterology
Recruiting
San Jose, California, United States, 95128
Contact: Huy Ngoc Trinh, Site 018
United States, Colorado
University Of Colorado Denver & Hospital
Recruiting
Aurora, Colorado, United States, 80045
Contact: Gregory Everson, Site 007 303-724-1877
United States, Maryland
Mercy Medical Center
Recruiting
Baltimore, Maryland, United States, 21202
Contact: Paul Thuluvath, Site 014 410-576-5389
United States, Massachusetts
Llc Dba The Research Institute
Recruiting
Springfield, Massachusetts, United States, 01107
Contact: Claudia T. Martorell, Site 002 413-747-5566
United States, Michigan
University Of Michigan Health System
Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Anna S. F. Lok, Site 009
United States, North Carolina
Charlotte Gastroenterology & Hepatology, Pllc
Recruiting
Charlotte, North Carolina, United States, 28207
Contact: John S. Hanson, Site 016 704-375-9485
Carolinas Center For Liver Disease
Recruiting
Statesville, North Carolina, United States, 28677
Contact: Robert W. Reindollar, Site 013 704-978-1144
United States, Texas
Reem H. Ghalib, Md
Recruiting
Arlington, Texas, United States, 76012
Contact: Reem H Ghalib, Site 012 817-471-1070
Alamo Medical Research
Recruiting
San Antonio, Texas, United States, 78215
Contact: Eric J. Lawitz, Site 003 210-253-3426
United States, Virginia
Metropolitan Research
Recruiting
Fairfax, Virginia, United States, 22031
Contact: Vinod K. Rustgi, Site 010 703-698-9254
No comments:
Post a Comment